Surgery Partners wins noteholder consents for merger-related bond amendments
Surgery Partners says its subsidiary secured the consents needed to amend $1,225M of 2032 notes ahead of a possible merger, with fees paid November 24.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
A subsidiary of Surgery Partners, Inc. (SGRY) has obtained the consents required to alter the indenture governing its $1,225.0 million 7.250% notes due 2032, according to a release reported by TradingView and distributed through GlobeNewswire. The changes take effect just before the merger closes, but only if that deal is actually completed.
Holders who signed on will receive a cash payment of $5.00 for every $1,000 in notes on November 24, 2026. The company's materials indicate this fee arrives regardless of whether the merger goes through. Principal, coupon and maturity stay untouched.
why it matters
For investors this is a procedural step tied to an already announced merger agreement, not proof that the deal has closed. Shareholder and regulatory approvals, the fulfilment of closing conditions and the merger itself remain ahead. Because the coupon and maturity are unchanged, the bonds' basic terms do not shift, and the fee is the only immediate cash flow for consenting holders.
tags
instruments
sources
- Surgery Partners, Inc. (SGRY) Gets Required Noteholder Consents for Merger-Related Changes — TradingView, 20 November 2026 at 22:49 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗